Gene · 7307
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunomodulatory Gene-Splicing Dysregulation in Tumorigenesis: Unmasking the Complexity. | Molecules | 2023 | 37630236 | PubTator, text mining | PubMed |
| Diagnosis- and Prognosis-Related Gene Alterations in BCR::ABL1-Negative Myeloproliferative Neoplasms. | Int J Mol Sci | 2023 | 37629188 | PubTator, text mining | PubMed |
| Changes in m6A in Steatotic Liver Disease. | Genes (Basel) | 2023 | 37628704 | PubTator, text mining | PubMed |
| Unveiling the Genetic Footprint: Exploring Somatic Mutations in Peripheral Arterial Disease Progression. | Biomedicines | 2023 | 37626784 | PubTator, text mining | PubMed |
| Individual with concurrent chest wall tuberculosis and triple-negative essential thrombocythemia: A case report. | World J Clin Cases | 2023 | 37621591 | PubTator, text mining | PubMed |
| Multiparameter prediction of myeloid neoplasia risk. | Nat Genet | 2023 | 37620601 | PubTator, text mining | PubMed |
| Methylation across the central dogma in health and diseases: new therapeutic strategies. | Signal Transduct Target Ther | 2023 | 37620312 | PubTator, text mining | PubMed |
| Histidine N1-position-specific methyltransferase CARNMT1 targets C3H zinc finger proteins and modulates RNA metabolism. | Genes Dev | 2023 | 37612136 | Swiss-Prot, curated | PubMed |
| Targeted NGS on sequential bone marrow biopsies aids in the evaluation of cytopenias and monocytosis and documents clonal evolution-a proof of principle study. | Virchows Arch | 2023 | 37610626 | PubTator, text mining | PubMed |
| Convergent somatic evolution commences in utero in a germline ribosomopathy. | Nat Commun | 2023 | 37608017 | PubTator, text mining | PubMed |
Next-generation sequencing of baseline genetic mutations and outcomes of eltrombopag and azacitidine therapy in patients with myelodysplastic syndromes and thrombocytopenia: Data from the SUPPORT clinical trial. | EJHaem | 2023 | 37601870 | PubTator, text mining | PubMed |
| Advances in management of primary myelofibrosis and polycythaemia vera: Implications in clinical practice. | EJHaem | 2023 | 37601853 | PubTator, text mining | PubMed |
| Presence but not number of secondary type mutations influences outcome in de novo AML without MDS-associated or recurring cytogenetic abnormalities. | EJHaem | 2023 | 37601841 | PubTator, text mining | PubMed |
| Genetic Predisposition to Clonal Hematopoiesis. | Hemasphere | 2023 | 37600859 | PubTator, text mining | PubMed |
| Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trial. | Blood | 2023 | 37595359 | PubTator, text mining | PubMed |
| A Rare Concurrence of Myelodysplastic Neoplasia and Tetrasomy 8 in a 3-Year-Old Bahraini Male. | Cureus | 2023 | 37593262 | PubTator, text mining | PubMed |
| Myelodysplastic neoplasm-associated U2AF1 mutations induce host defense defects by compromising neutrophil chemotaxis. | Leukemia | 2023 | 37591942 | PubTator, text mining | PubMed |
| Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients. | Leukemia | 2023 | 37591941 | PubTator, text mining | PubMed |
| Perspectives on acute myeloid leukemia diagnosis: a comparative analysis of the latest World Health Organization and the International Consensus Classifications. | Leukemia | 2023 | 37580414 | PubTator, text mining | PubMed |
| Clinical Characteristics and Outcomes of Patients with Primary and Secondary Myelofibrosis According to the Genomic Classification Using Targeted Next-Generation Sequencing. | Cancers (Basel) | 2023 | 37568719 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7307/papers?page=20